EP Patent

EP0219762B1 — Verfahren zur Herstellung einer Darreichungs- und Dosierungsform für Arzneimittel-Wirkstoffe, Reagentien oder andere Wirkstoffe

Assigned to LTS Lohmann Therapie Systeme AG · Expires 1990-12-27 · 35y expired

What this patent protects

Patent listed against apomorphine-hydrochloride.

Drugs covered by this patent

apomorphine-hydrochloride (APOMORPHINE HYDROCHLORIDE)

Patent Metadata

Patent number: EP0219762B1
Jurisdiction: EP
Classification: —
Expires: 1990-12-27
Drug substance claim: No
Drug product claim: No
Assignee: LTS Lohmann Therapie Systeme AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.